Search results
ASCO24: Can Ambrx’s novel ADC break into the metastatic breast cancer market?
Pharmaceutical Technology via Yahoo Finance· 1 hour agoIn ACE-Breast-02, ARX788 managed to prolong progression-free survival (PFS) compared to LC, with...
Study: Sepsis quality metrics may unfairly penalize safety-net hospitals
Center for Infectious Disease Research and Policy· 5 hours agoResearchers found in-hospital mortality was higher at safety-net hospitals than non–safety-net...
Hypertension, albuminuria risks are no worse for kidney donors than for non-donors: Study
Medical Xpress· 4 days agoLiving kidney donors and non-donors have similar risks for hypertension and albuminuria, according...
Sustained bias of spatial attention in a 3 T MRI scanner - Scientific Reports
Nature· 22 hours agoWhen lying inside a MRI scanner and even in the absence of any motion, the static magnetic field of MRI scanners induces a magneto-hydrodynamic stimulation of subjects’ vestibular organ (MVS ...
Determinants of incomplete penta vaccination among children aged 12 to 23 months in South-West...
Nature· 4 days agoA Community based case–control study was conducted at Illu Aba Bor, mettu district, south west Ethiopia from April 24-May 23, 2022. Mettu is located in Oromia Regional State at a distance of ...
Marfan’s syndrome is associated with a greater risk of Peyronie’s disease: a case-control study of...
Nature· 5 days agoThe association between men’s sexual health diseases (MSHD) and connective tissue disorders (CTD) has not been well studied. A relatively common MSHD is Peyronie’s disease (PD), which is characterized ...
Exploring high-quality microbial genomes by assembling short-reads with long-range connectivity -...
Nature· 4 days agoHere, the authors develop Pangaea, an assembler that uses short-reads with long-range connectivity to create high-quality microbial genomes affordably, showing it outperforms existing methods ...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 2 days ago- Clinically meaningful and statistically significant improvements across multiple angioedema measurements and barzolvolimab dose groups -- Sustained activity with rapid onset within 2 weeks -- Data further support barzolvolimab clinical benefit
Medicenna Reports Significant Survival Benefit in Patients with Recurrent Glioblastoma Following...
Digital Journal· 17 hours agoMedicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines, presented updated clinical ...
May 31 2024 This Week in Cardiology
Medscape· 4 days agoFor more insight and commentary on these stories, subscribe to the This Week in Cardiology podcast, download the Medscape app or subscribe on Apple...
